PALISADE BIO, INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q3 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Palisade Bio, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q3 2019 to Q3 2024.
  • Palisade Bio, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $113K, a 49.6% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $113K -$111K -49.6% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $142K -$108K -43.2% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $170K -$105K -38.2% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $198K -$102K -34% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 $224K -$100K -30.9% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $250K -$113K -31.1% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $275K +$211K +330% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $300K +$191K +175% Dec 31, 2022 10-K 2024-03-26
Q3 2022 $324K +$171K +112% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $363K +$168K +86.2% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $64K Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $109K -$166K -60.4% Dec 31, 2021 10-K 2023-03-22
Q3 2021 $153K Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $195K Jun 30, 2021 10-Q 2021-08-23
Q4 2020 $275K +$70.7K +34.6% Dec 31, 2020 10-K 2022-03-17
Q4 2019 $204K Dec 31, 2019 10-K 2021-03-22
Q3 2019 $204K Sep 30, 2019 10-Q 2019-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.